Inhibition of Oxidative Stress and Related Signaling Pathways in Neuroprotection
Acknowledgments
Conflicts of Interest
References
- Olufunmilayo, E.O.; Gerke-Duncan, M.B.; Holsinger, R.M.D. Oxidative Stress and Antioxidants in Neurodegenerative Disorders. Antioxidants 2023, 12, 517. [Google Scholar] [CrossRef]
- Verma, M.; Lizama, B.N.; Chu, C.T. Excitotoxicity, calcium and mitochondria: A triad in synaptic neurodegeneration. Transl. Neurodegener. 2022, 11, 3. [Google Scholar] [CrossRef] [PubMed]
- Kwon, H.S.; Koh, S.H. Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes. Transl. Neurodegener. 2020, 9, 42. [Google Scholar] [CrossRef]
- Zhang, M.; He, Q.; Chen, G.; Li, P.A. Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson’s Disease. Neurodegener. Dis. 2020, 20, 73–83. [Google Scholar] [CrossRef]
- Wu, K.J.; Wang, W.R.; Cheng, Q.H.; Li, H.; Yan, W.Z.; Zhou, F.R.; Zhang, R.J. Pyroptosis in neurodegenerative diseases: From bench to bedside. Cell Biol. Toxicol. 2023, 39, 2467–2499. [Google Scholar] [CrossRef]
- Schirinzi, T.; Canevelli, M.; Suppa, A.; Bologna, M.; Marsili, L. The continuum between neurodegeneration, brain plasticity, and movement: A critical appraisal. Rev. Neurosci. 2020, 31, 723–742. [Google Scholar] [CrossRef] [PubMed]
- McBean, G.J.; López, M.G.; Wallner, F.K. Redox-based therapeutics in neurodegenerative disease. Br. J. Pharmacol. 2017, 174, 1750–1770. [Google Scholar] [CrossRef] [PubMed]
- Redza-Dutordoir, M.; Averill-Bates, D.A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim. Biophys. Acta 2016, 1863, 2977–2992. [Google Scholar] [CrossRef]
- Lee, K.H.; Cha, M.; Lee, B.H. Crosstalk between Neuron and Glial Cells in Oxidative Injury and Neuroprotection. Int. J. Mol. Sci. 2021, 22, 13315. [Google Scholar] [CrossRef]
- Dong-Chen, X.; Yong, C.; Yang, X.; Chen-Yu, S.; Li-Hua, P. Signaling pathways in Parkinson’s disease: Molecular mechanisms and therapeutic interventions. Signal Transduct. Target. Ther. 2023, 8, 73. [Google Scholar] [CrossRef]
- Sivandzade, F.; Prasad, S.; Bhalerao, A.; Cucullo, L. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches. Redox Biol. 2019, 21, 101059. [Google Scholar] [CrossRef] [PubMed]
- Sharma, V.; Kaur, A.; Singh, T.G. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer’s disease. Biomed. Pharmacother. 2020, 129, 110373. [Google Scholar] [CrossRef] [PubMed]
- Wu, S.; Liao, X.; Zhu, Z.; Huang, R.; Chen, M.; Huang, A.; Zhang, J.; Wu, Q.; Wang, J.; Ding, Y. Antioxidant and anti-inflammation effects of dietary phytochemicals: The Nrf2/NF-κB signalling pathway and upstream factors of Nrf2. Phytochemistry 2022, 204, 113429. [Google Scholar] [CrossRef] [PubMed]
- Hennig, P.; Garstkiewicz, M.; Grossi, S.; Di Filippo, M.; French, L.E.; Beer, H.-D. The Crosstalk between Nrf2 and Inflammasomes. Int. J. Mol. Sci. 2018, 19, 562. [Google Scholar] [CrossRef] [PubMed]
- Clifford, T.; Acton, J.P.; Cocksedge, S.P.; Davies, K.A.B.; Bailey, S.J. The effect of dietary phytochemicals on nuclear factor erythroid 2-related factor 2 (Nrf2) activation: A systematic review of human intervention trials. Mol. Biol. Rep. 2021, 48, 1745–1761. [Google Scholar] [CrossRef]
- Rai, S.N.; Dilnashin, H.; Birla, H.; Singh, S.S.; Zahra, W.; Rathore, A.S.; Singh, B.K.; Singh, S.P. The Role of PI3K/Akt and ERK in Neurodegenerative Disorders. Neurotox. Res. 2019, 35, 775–795. [Google Scholar] [CrossRef]
- Naoi, M.; Shamoto-Nagai, M.; Maruyama, W. Neuroprotection of multifunctional phytochemicals as novel therapeutic strategy for neurodegenerative disorders: Antiapoptotic and antiamyloidogenic activities by modulation of cellular signal pathways. Future Neurol. 2019, 14, FNL9. [Google Scholar] [CrossRef]
- Jazvinšćak Jembrek, M.; Vlainić, J.; Čadež, V.; Šegota, S. Atomic force microscopy reveals new biophysical markers for monitoring subcellular changes in oxidative injury: Neuroprotective effects of quercetin at the nanoscale. PLoS ONE 2018, 13, e0200119. [Google Scholar] [CrossRef]
- Kessas, K.; Lounis, W.; Chouari, Z.; Vejux, A.; Lizard, G.; Kharoubi, O. Benefits of rutin on mitochondrial function and inflammation in an aluminum-induced neurotoxicity rat model: Potential interest for the prevention of neurodegeneration. Biochimie 2024, 222, 1–8. [Google Scholar] [CrossRef]
- Wu, X.; Wei, J.; Yi, Y.; Shu, G.; He, Z.; Gong, Q.; Gao, J. Epimedium Aqueous Extract Ameliorates Cerebral Ischemia/Reperfusion Injury through Inhibiting ROS/NLRP3-Mediated Pyroptosis. Antioxidants 2023, 12, 999. [Google Scholar] [CrossRef]
- Guan, Y.; Han, F. Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases. Front. Integr. Neurosci. 2020, 14, 37. [Google Scholar] [CrossRef]
- Liu, Z.; Tu, K.; Zou, P.; Liao, C.; Ding, R.; Huang, Z.; Huang, Z.; Yao, X.; Chen, J.; Zhang, Z. Hesperetin ameliorates spinal cord injury by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling. Int. Immunopharmacol. 2023, 118, 110103. [Google Scholar] [CrossRef] [PubMed]
- Huang, Y.; Li, X.; Luo, G.; Wang, J.; Li, R.; Zhou, C.; Wan, T.; Yang, F. Pyroptosis as a candidate therapeutic target for Alzheimer’s disease. Front. Aging Neurosci. 2022, 14, 996646. [Google Scholar] [CrossRef] [PubMed]
- Suleymanova, E.M.; Karan, A.A.; Borisova, M.A.; Volobueva, M.N.; Bolshakov, A.P. Expression of Cytokines and Neurodegeneration in the Rat Hippocampus and Cortex in the Lithium-Pilocarpine Model of Status Epilepticus and the Role of Modulation of Endocannabinoid System. Int. J. Mol. Sci. 2023, 24, 6509. [Google Scholar] [CrossRef]
- Mukhtar, I. Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: From pathogenesis to treatment target. Seizure 2020, 82, 65–79. [Google Scholar] [CrossRef] [PubMed]
- Foiadelli, T.; Santangelo, A.; Costagliola, G.; Costa, E.; Scacciati, M.; Riva, A.; Volpedo, G.; Smaldone, M.; Bonuccelli, A.; Clemente, A.M.; et al. Neuroinflammation and status epilepticus: A narrative review unraveling a complex interplay. Front. Pediatr. 2023, 11, 1251914. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.F.; Wang, H.; Fan, Y.; Shi, H.J.; Wang, Q.M.; Chen, B.R.; Khurwolah, M.R.; Long, Q.Q.; Wang, S.B.; Wang, Z.M.; et al. Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the TLR4/MAPK/NF-κB Signalling Pathway in Lipopolysaccharide-Induced Macrophages. Cell Physiol. Biochem. 2017, 43, 926–936. [Google Scholar] [CrossRef]
- Mokra, D.; Joskova, M.; Mokry, J. Therapeutic Effects of Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis. Int. J. Mol. Sci. 2023, 24, 340. [Google Scholar] [CrossRef]
- Kim, J.-E.; Park, H.; Kang, T.-C. Peroxiredoxin 6 Regulates Glutathione Peroxidase 1-Medited Glutamine Synthase Preservation in the Hippocampus of Chronic Epilepsy Rats. Antioxidants 2023, 12, 156. [Google Scholar] [CrossRef]
- Xue, M.; Huang, X.; Zhu, T.; Zhang, L.; Yang, H.; Shen, Y.; Feng, L. Unveiling the Significance of Peroxiredoxin 6 in Central Nervous System Disorders. Antioxidants 2024, 13, 449. [Google Scholar] [CrossRef]
- Kang, B.-S.; Choi, B.-Y.; Kho, A.-R.; Lee, S.-H.; Hong, D.-K.; Park, M.-K.; Lee, S.-H.; Lee, C.-J.; Yang, H.-W.; Woo, S.-Y.; et al. Effects of Pyruvate Kinase M2 (PKM2) Gene Deletion on Astrocyte-Specific Glycolysis and Global Cerebral Ischemia-Induced Neuronal Death. Antioxidants 2023, 12, 491. [Google Scholar] [CrossRef]
- Alquraishi, M.; Puckett, D.L.; Alani, D.S.; Humidat, A.S.; Frankel, V.D.; Donohoe, D.R.; Whelan, J.; Bettaieb, A. Pyruvate kinase M2: A simple molecule with complex functions. Free Radic. Biol. Med. 2019, 143, 176–192. [Google Scholar] [CrossRef] [PubMed]
- Dhanesha, N.; Patel, R.B.; Doddapattar, P.; Ghatge, M.; Flora, G.D.; Jain, M.; Thedens, D.; Olalde, H.; Kumskova, M.; Leira, E.C.; et al. PKM2 promotes neutrophil activation and cerebral thromboinflammation: Therapeutic implications for ischemic stroke. Blood 2022, 139, 1234–1245. [Google Scholar] [CrossRef] [PubMed]
- Li, X.; Zhou, R.; Peng, H.; Peng, J.; Li, Q.; Mei, M. Microglia PKM2 Mediates Neuroinflammation and Neuron Loss in Mice Epilepsy through the Astrocyte C3-Neuron C3R Signaling Pathway. Brain Sci. 2023, 13, 262. [Google Scholar] [CrossRef]
- McLeary, F.; Davis, A.; Rudrawar, S.; Perkins, A.; Anoopkumar-Dukie, S. Mechanisms underlying select chemotherapeutic-agent-induced neuroinflammation and subsequent neurodegeneration. Eur. J. Pharmacol. 2019, 842, 49–56. [Google Scholar] [CrossRef]
- Boadas-Vaello, P.; Vela, J.M.; Verdu, E. New Pharmacological Approaches Using Polyphenols on the Physiopathology of Neuropathic Pain. Curr. Drug Targets 2017, 18, 160–173. [Google Scholar] [CrossRef] [PubMed]
- Siddiqui, M.; Abdellatif, B.; Zhai, K.; Liskova, A.; Kubatka, P.; Büsselberg, D. Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs. Cancers 2021, 13, 1576. [Google Scholar] [CrossRef] [PubMed]
- Essmat, A.; Hussein, M.S. Green tea extract for mild-to-moderate diabetic peripheral neuropathy A randomized controlled trial. Complement. Ther. Clin. Pract. 2021, 43, 101317. [Google Scholar] [CrossRef]
- Palomino, O.; García-Aguilar, A.; González, A.; Guillén, C.; Benito, M.; Goya, L. Biological Actions and Molecular Mechanisms of Sambucus nigra L. in Neurodegeneration: A Cell Culture Approach. Molecules 2021, 26, 4829. [Google Scholar] [CrossRef]
- Neves, D.; Valentão, P.; Bernardo, J.; Oliveira, M.C.; Ferreira, J.M.G.; Pereira, D.M.; Andrade, P.B.; Videira, R.A. A new insight on elderberry anthocyanins bioactivity: Modulation of mitochondrial redox chain functionality and cell redox state. J. Funct. Foods 2019, 56, 145–155. [Google Scholar] [CrossRef]
- Merecz-Sadowska, A.; Sitarek, P.; Zajdel, K.; Sztandera, W.; Zajdel, R. Genus Sambucus: Exploring Its Potential as a Functional Food Ingredient with Neuroprotective Properties Mediated by Antioxidant and Anti-Inflammatory Mechanisms. Int. J. Mol. Sci. 2024, 25, 7843. [Google Scholar] [CrossRef]
- Kamrul-Hasan, A.B.M.; Alam, M.S.; Talukder, S.K.; Dutta, D.; Selim, S. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Endocrinol. Metab. 2024, 39, 109–126. [Google Scholar] [CrossRef]
- Ayoub, B.M.; Michel, H.E.; Mowaka, S.; Hendy, M.S.; Tadros, M.M. Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS. Molecules 2021, 26, 889. [Google Scholar] [CrossRef] [PubMed]
- Erbil, D.; Eren, C.Y.; Demirel, C.; Küçüker, M.U.; Solaroğlu, I.; Eser, H.Y. GLP-1’s role in neuroprotection: A systematic review. Brain Inj. 2019, 33, 734–819. [Google Scholar] [CrossRef]
- Gouda, N.A.; Cho, J. Omarigliptin Mitigates 6-Hydroxydopamine- or Rotenone-Induced Oxidative Toxicity in PC12 Cells by Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Actions. Antioxidants 2022, 11, 1940. [Google Scholar] [CrossRef] [PubMed]
- Dawson, T.M.; Golde, T.E.; Lagier-Tourenne, C. Animal models of neurodegenerative diseases. Nat. Neurosci. 2018, 21, 1370–1379. [Google Scholar] [CrossRef] [PubMed]
- Marshall, L.J.; Bailey, J.; Cassotta, M.; Herrmann, K.; Pistollato, F. Poor Translatability of Biomedical Research Using Animals—A Narrative Review. Altern. Lab. Anim. 2023, 51, 102–135. [Google Scholar] [CrossRef] [PubMed]
- Tello, J.A.; Williams, H.E.; Eppler, R.M.; Steinhilb, M.L.; Khanna, M. Animal Models of Neurodegenerative Disease: Recent Advances in Fly Highlight Innovative Approaches to Drug Discovery. Front. Mol. Neurosci. 2022, 15, 883358. [Google Scholar] [CrossRef]
- Vuic, B.; Milos, T.; Tudor, L.; Konjevod, M.; Nikolac Perkovic, M.; Jazvinscak Jembrek, M.; Nedic Erjavec, G.; Svob Strac, D. Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential. Biomedicines 2022, 10, 3000. [Google Scholar] [CrossRef]
- Kaszyńska, A.A. Cannabinoids: Potential for Modulation and Enhancement When Combined with Vitamin B12 in Case of Neurodegenerative Disorders. Pharmaceuticals 2024, 17, 813. [Google Scholar] [CrossRef]
- Tadijan, A.; Vlašić, I.; Vlainić, J.; Đikić, D.; Oršolić, N.; Jazvinšćak Jembrek, M. Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions. Antioxidants 2022, 11, 2049. [Google Scholar] [CrossRef] [PubMed]
- Voicu, V.; Brehar, F.-M.; Toader, C.; Covache-Busuioc, R.-A.; Corlatescu, A.D.; Bordeianu, A.; Costin, H.P.; Bratu, B.-G.; Glavan, L.-A.; Ciurea, A.V. Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy. Biomolecules 2023, 13, 1388. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Jembrek, M.J. Inhibition of Oxidative Stress and Related Signaling Pathways in Neuroprotection. Antioxidants 2024, 13, 1033. https://doi.org/10.3390/antiox13091033
Jembrek MJ. Inhibition of Oxidative Stress and Related Signaling Pathways in Neuroprotection. Antioxidants. 2024; 13(9):1033. https://doi.org/10.3390/antiox13091033
Chicago/Turabian StyleJembrek, Maja Jazvinšćak. 2024. "Inhibition of Oxidative Stress and Related Signaling Pathways in Neuroprotection" Antioxidants 13, no. 9: 1033. https://doi.org/10.3390/antiox13091033